An observational study to characterize severe eosinophilic asthma in New Zealand

被引:2
|
作者
Shantakumar, Sumitra [1 ]
Ho, Yu-Fan [1 ]
Beale, Janine [2 ]
Gribben, Barry [3 ]
机构
[1] GlaxoSmithKline, Singapore, Singapore
[2] GlaxoSmithKline, Auckland, New Zealand
[3] CBG Hlth Res, Auckland, New Zealand
关键词
D O I
10.1183/13993003.congress-2018.PA1155
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
PA1155
引用
收藏
页数:2
相关论文
共 50 条
  • [1] A retrospective observational study to characterize severe eosinophilic asthma in Taiwan
    Shantakumar, Sumitra
    Ho, Yu-Fan
    Tuan, Li-Wen
    Lin, Tsu-Mei
    Chen, Yi-Hsing
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [2] Characterization and burden of severe eosinophilic asthma in New Zealand: Results from the HealthStat Database
    Shantakumar, Sumitra
    Ho, Yu-Fan
    Beale, Janine
    Gribben, Barry
    MULTIDISCIPLINARY RESPIRATORY MEDICINE, 2020, 15
  • [3] A single-center observational study assessing response to mepolizumab in severe eosinophilic asthma
    Tan, Nadia Suray
    Mukherjee, Manali
    Lim, Sheau Yng
    Thiam, Chung Hwee
    Tan, W. S. Daniel
    Wong, W. S. Fred
    Nair, Parameswaran
    Angeli, Veronique
    Lim, Hui Fang
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [4] Primary care of asthma: new options for severe eosinophilic asthma
    Skolnik, Neil S.
    Carnahan, Sean P.
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (07) : 1309 - 1318
  • [5] Early and Sustained Response to Benralizumab in Severe, Eosinophilic Asthma: A Real-World Observational Study
    Stolz, Daiana
    Schuoler, Claudio
    Charbonnier, Florian
    Bridevaux, Pierre-Olivier
    Jandus, Peter
    Leuppi, Joerg
    Pavlov, Nikolay
    Piecyk, Andreas
    Rothe, Thomas
    JOURNAL OF ASTHMA AND ALLERGY, 2024, 17 : 1301 - 1312
  • [6] Real-world outcomes of mepolizumab for the treatment of severe eosinophilic asthma in Canada: an observational study
    Chapman, Kenneth R.
    Cogger, Kathryn
    Arthurs, Erin
    LaForty, Callahan
    Golden, Shane
    Millson, Bradley
    Usuba, Koyo
    Licskai, Christopher
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2024, 20 (01):
  • [7] Real-world outcomes of mepolizumab for the treatment of severe eosinophilic asthma in Canada: an observational study
    Kenneth R. Chapman
    Kathryn Cogger
    Erin Arthurs
    Callahan LaForty
    Shane Golden
    Bradley Millson
    Koyo Usuba
    Christopher Licskai
    Allergy, Asthma & Clinical Immunology, 20
  • [8] Severe Eosinophilic Asthma
    Bakakos, Agamemnon
    Loukides, Stelios
    Bakakos, Petros
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (09)
  • [9] Benralizumab: A New Approach for the Treatment of Severe Eosinophilic Asthma
    Gonzalez I, Davila
    Benitez F, Moreno
    Quirce, S.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2019, 29 (02) : 84 - 93
  • [10] The prevalence of severe asthma and severe eosinophilic asthma in Finland
    Viinanen, Arja
    Ilmarinen, Pinja
    Mehtala, Juha
    Ylisaukko-Oja, Tero
    Idanpaan-Heikkila, Juhana J.
    Kankaanranta, Hannu
    Lehtimaki, Lauri
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62